Research programme: antibacterials - Alchemia

Drug Profile

Research programme: antibacterials - Alchemia

Alternative Names: Antibacterials research programme - Alchemia; VT 16773

Latest Information Update: 07 May 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alchemia
  • Class Small molecules
  • Mechanism of Action Peptidoglycan glycosyltransferase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical Bacterial infections

Most Recent Events

  • 07 May 2010 Preclinical development is ongoing in Australia
  • 09 Aug 2006 Optimisation studies are ongoing
  • 29 Jun 2004 Preclinical trials in Bacterial infections in Australia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top